CD40 on NOD CD4 T cells contributes to their activation and pathogenicity

Journal of Autoimmunity

Volumn 31, Issue 4, 2008, Pages 385-392

  Baker, Rocky L ^a   Wagner Jr , David H ^a   Haskins, Kathryn ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

CD4 T cells; CD40; NOD; Type 1 diabetes

Indexed keywords

CD28 ANTIGEN; CD40 LIGAND; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL PROLIFERATION; CELL STIMULATION; FEMALE; HOMEOSTASIS; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PATHOGENICITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELL LINE; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 56549110891     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.09.001     Document Type: Article

References (33)

1. van Kooten C., and Banchereau J. CD40-CD40 ligand. J Leukoc Biol 67 (2000) 2-17
2. Bhushan A., and Covey L.R. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes. Immunol Res 24 (2001) 311-324
3. Lougaris V., Badolato R., Ferrari S., and Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev 203 (2005) 48-66
4. Bishop G.A., Moore C.R., Xie P., Stunz L.L., and Kraus Z.J. TRAF proteins in CD40 signaling. Adv Exp Med Biol 597 (2007) 131-151
5. Notarangelo L.D., Duse M., and Ugazio A.G. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 3 (1992) 101-121
6. + T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur J Immunol 24 (1994) 3148-3154
7. Shu U., Kiniwa M., Wu C.Y., Maliszewski C., Vezzio N., Hakimi J., et al. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 25 (1995) 1125-1128
8. Yellin M.J., Brett J., Baum D., Matsushima A., Szabolcs M., Stern D., et al. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med 182 (1995) 1857-1864
9. Datta S.K., and Kalled S.L. CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum 40 (1997) 1735-1745
10. Schonbeck U., and Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 58 (2001) 4-43
11. Wagner Jr. D.H., Vaitaitis G., Sanderson R., Poulin M., Dobbs C., and Haskins K. Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc Natl Acad Sci U S A 99 (2002) 3782-3787
12. + auto-aggressive T cell expansion during insulin-dependent diabetes mellitus. Eur J Immunol 34 (2004) 1488-1497
13. + T cells (TCD40) in human type 1 diabetes. Clin Immunol 124 (2007) 138-148
14. Munroe M.E., and Bishop G.A. A costimulatory function for T cell CD40. J Immunol 178 (2007) 671-682
15. Fanslow W.C., Clifford K.N., Seaman M., Alderson M.R., Spriggs M.K., Armitage R.J., et al. Recombinant CD40 ligand exerts potent biologic effects on T cells. J Immunol 152 (1994) 4262-4269
16. + T cell memory. Science 297 (2002) 2060-2063
17. Vaitaitis G.M., Poulin M., Sanderson R.J., Haskins K., and Wagner Jr. D.H. Cutting edge: CD40-induced expression of recombination activating gene (RAG) 1 and RAG2: a mechanism for the generation of autoaggressive T cells in the periphery. J Immunol 170 (2003) 3455-3459
18. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12 (2000) 431-440
19. Arreaza G.A., Cameron M.J., Jaramillo A., Gill B.M., Hardy D., Laupland K.B., et al. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism. J Clin Invest 100 (1997) 2243-2253
20. Bour-Jordan H., and Bluestone J.A. CD28 function: a balance of costimulatory and regulatory signals. J Clin Immunol 22 (2002) 1-7
21. Amrani A., Serra P., Yamanouchi J., Han B., Thiessen S., Verdaguer J., et al. CD154-dependent priming of diabetogenic CD4(+) T cells dissociated from activation of antigen-presenting cells. Immunity 16 (2002) 719-732
22. Balasa B., Krahl T., Patstone G., Lee J., Tisch R., McDevitt H.O., et al. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J Immunol 159 (1997) 4620-4627
23. Kawai T., Andrews D., Colvin R.B., Sachs D.H., and Cosimi A.B. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 6 (2000) 114
24. Haskins K. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv Immunol 87 (2005) 123-162
25. Haskins K., Portas M., Bradley B., Wegmann D., and Lafferty K. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37 (1988) 1444-1448
26. Haskins K., Portas M., Bergman B., Lafferty K., and Bradley B. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci U S A 86 (1989) 8000-8004
27. Bergman B., and Haskins K. Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes 43 (1994) 197-203
28. Yoshida K., Martin T., Yamamoto K., Dobbs C., Munz C., Kamikawaji N., et al. Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones. Int Immunol 14 (2002) 1439-1447
29. Cantor J., and Haskins K. Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha. J Immunol 175 (2005) 7738-7745
30. Teft W.A., Kirchhof M.G., and Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 24 (2006) 65-97
31. Dahlen E., Hedlund G., and Dawe K. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation. J Immunol 164 (2000) 2444-2456
32. Perkins D., Wang Z., Donovan C., He H., Mark D., Guan G., et al. Regulation of CTLA-4 expression during T cell activation. J Immunol 156 (1996) 4154-4159
33. Piganelli J.D., Poulin M., Martin T., Allison J.P., and Haskins K. Cytotoxic T lymphocyte antigen 4 (CD152) regulates self-reactive T cells in BALB/c but not in the autoimmune NOD mouse. J Autoimmun 14 (2000) 123-131